Melanoma Evidence & Self-Care · education / decision-support

← Evidence library

BIB_201

NICE TA410 — Talimogene laherparepvec (T-VEC) for unresectable Stage IIIB-IVM1a melanoma. 2016. Intralesional oncolytic. [Tasks: 19a, 18] Tier: 2 Grade: N/A Retrieved: 2026-05-07

Evidence grade
N/A
Tier
2
Cited by tasks
19a, 18
Identifiers

Full extracted findings & patient-implication analysis: bibliography/BIB_201/findings.md (research corpus). This page is a short context summary — not individualised medical advice.